Luca Arecco: First insights from GIM23 about adjuvant ET in premenopausal patients

Luca Arecco, Medical Oncology Resident at IRCCS Ospedale Policlinico San Martino, on X about recent paper by him as first author, titled “Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study” published on The Breast Online.

Authors: Luca Arecco, Maria Maddalena Latocca, Eva Blondeaux, Ferdinando Riccardi, Carmela Mocerino, Valentina Guarneri, Eleonora Mioranza, Giancarlo Bisagni, Elisa Gasparini, Fabio Puglisi, Alexandro Membrino, Antonella Ferro, Vincenzo Adamo, Filippo Giovanardi, Stefano Tamberi, Sara Donati, Elisabetta Landucci, Laura Biganzoli, Sara Piccininia, Simona Pastorino, Evandro de Azambuja, Francesca Poggio, Matteo Lambertini, Lucia Del Mastro.

“Which is the most prescribed adjuvant ET in premenopausal patients? And which criteria determine this choice?

We published in The Breast Online first insights from GIM23 study answering some of these questions!”

Source: Luca Arecco/X